A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data
Article in Journal of Diabetes Investigation (June 2024)
The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.
Tirzepatide use and the risk of cancer among individuals with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
Article in Diabetes Research and Clinical Practice (June 2024)
Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system
Article in Frontiers in Pharmacology (June 2024)